Catalyst Wire Dossier Catalyst Wire Dossier

BI 201335 (faldaprevir)

faldaprevir · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 201335 (faldaprevir), covering 2015-08-03 to 2015-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Drug-drug Interaction of BI 201335 and Microgynon [Phase 1]

See pricing